Laminar Pharma

Lipopharma [2007] is a pioneering biopharmaceutical company that focuses on the discovery, rational design and initial clinical development of a new generation of medicines associated with a novel therapeutic approach: Membrane Lipid Therapy (MLT). Lipopharma arose as an academic spin-off to develop commercially new scientific know-how and applications generated by reputable scientists at the Institute of Health Science Research (IUNICS) at the University of the Balearic Islands (Spain). Membrane Lipid Therapy (MLT) is an innovative and unique technology platform that is based on very specialized scientific knowledge, which allows us to confidently embark on the rational design of new molecules that regulate the structure and function of cell membrane lipids, and their associated proteins. Recent advances in our understanding of lipid membrane structures and their interactions with peripheral signal transduction proteins have opened the way to develop synthetic lipids that target cell membranes. This approach has led to the development of novel and alternative therapeutic strategies for a number of important pathologies such as Cancer, Neurodegenerative diseases, Metabolic disorders or Inflammation.